| |
|
|
|
 |
Biography
Benjamin J. Ansell, MD FACP/FACC
Director,
UCLA Comprehensive Health Program |
|
Benjamin J. Ansell, MD, received a dual undergraduate
degree with distinction in Biology and as a College Scholar
in Music from Cornell University, followed by his Doctor
of Medicine from the University of California Los Angeles
(UCLA) School of Medicine. He subsequently performed an
internship and residency in Internal Medicine at the UCLA
Medical Center. Dr. Ansell currently serves as Professor at the David Geffen School of Medicine at UCLA
in the Divisions of General Internal
Medicine and Cardiology. He is also Director of the Comprehensive Health
Program, Co-Director of Cholesterol, Hypertension,
and Atherosclerosis Management Program (CHAMP) and the Medical Hospitality Program at UCLA.
Dr. Ansell is a member of the American Heart Association Council on Arteriosclerosis, Thrombosis, and Vascular Biology, and certified by the American Boards of Internal Medicine and Clinical Lipidology. He has been elected as a Fellow of the American College of Physicians, the American College of Cardiology, and the National Lipid Association. He is a member of the Board of the National Lipid Association, past member of the Board of the Pacific Lipid Association, past President of the Executive Board of the UCLA Department of Medicine Professional Group, and current member of the Managed Care Utilization Review Committee of the UCLA Medical Group. Dr. Ansell is the founder and director of the
Cardiovascular Discovery Fund, which supports promising novel developments in heart disease and related conditions. He has also served as a Director of the Ashford Hospitality Trust (NYSE: AHT) since 2009.
Listed among US News and Castle-Connolly’s “America’s Top Doctors” and chosen by Town & Country magazine as one of the "Best
Physicians in America," Dr. Ansell has a range of research
experience relating to cholesterol treatment strategies in preventing and managing cardiovascular diseases. He has been principal
investigator of the hs-CRP and HDL Effects of Statins
Trial (CHEST), the Statins/HDL Increased Function Trial
(SHIFT), and the Statin Anti-Rheumatic Activity (SARA)
Trial. He is on the review boards of the Journal of the American College of Cardiology, The American Journal of Cardiology,
and the Journal of General Internal Medicine, among others. He has delivered approximately two hundred invited lectures, as well as published 40 peer-reviewed papers in the Journal of the American Medical Association, Journal of the American College of Cardiology,
Circulation, Archives
of Internal Medicine, and the American Journal of Cardiology,
among others. His publications have focused on HDL (high-density lipoprotein) and inflammation, cholesterol
management, stroke reduction, cardiovascular risk reduction
in women, and national cholesterol guidelines. He has
also been featured by The New York Times, The
Los Angeles Times, National Public Radio,
Glamour Magazine, ABC World News Tonight, MSNBC, and Dateline NBC.
Previously from New York state and Colorado, Dr. Ansell
has lived in Los Angeles for the last twenty-three years.
He is married with three children with whom he enjoys playing
outdoor sports. He supports the performing arts and is a member of the Board of Overseers for the Los Angeles Philharmonic. Dr. Ansell's medical philosophy
favors early disease detection and prevention. It is his
professional goal to translate the frontiers of medical
knowledge into benefits for patients today.
|
|
|
|
|
|
|
|
